baber/WOPTO huggingface dataset:
Patent AU-4438489-A (AU)
Title: Pharmaceutical compositions containing n-(3,4- dimethoxycinnamoyl)anthranilic acid
IPC: A61K31/195
Filed: 1989-11-03
Abstract: This invention provides a pharmaceutical composition for the treatment of allergic conjunctivitis or allergic rhinitis. The composition is an aqueous solution containing N-(3,4-dimethoxycinnamoyl)anthranilic acid or a pharmaceutically acceptable salt thereof as an active ingredient. The composition additionally contains as essential components polyvinylpyrrolidone, a basic compound and a surface active agent and the composition has a pH of about 6.5-8.5.
Patent AU-4648385-A (AU)
Title: Shower Partition
Inventor: BAUS HEINZ GEORG
IPC: E05D5/02
Filed: 1985-08-21
Abstract: A shower partition includes a swinging door pivotable, by means of a hinge, about a substantially vertical axis. The installation dimensions available at the installation site often vary widely, discrepancies of up to 20 cm being by no means unusual. Compensation for tolerances or variations in installation dimensions is made possible in a simple manner. To this end, the swinging door is constructed so that it can be adjusted at right angles to its pivot axis on a jamb member or the like. The swinging door, and/or the pivot hinge comprise, at right angles to the pivot axis, a slot or a series of spaced aligned holes for an attachment element such as a screw.
Patent AU-4837985-A (AU)
Title: Cutting oil
Inventor: RAWLINSON ANTHONY PAUL
IPC: C10M173/00
Filed: 1985-10-08
Abstract: A composition for the preparation of a soluble-oil for use in a cutting fluid comprises a mineral oil and, as an emulsifier, an effective amount of a sulphonate of a branched polymer of a C<sub>3</sub> to C<sub>5</sub> olefin. Preferably the polyolefin chain of the sulphonate has an average molecular weight in the range 275 to 560 and the polyolefin is polyisobutene.A soluble-oil can be prepared from the above composition by the addition of a conventional corrosion inhibitor and diluted with water to make a cutting fluid. Advantages of the novel emulsifier are that they are resistant to breakdown by micro-organisms and do not require the addition of a coupling agent.
Patent AU-5062996-A (AU)
Title: Novel pyridine compounds, processes for their preparation and the pharmaceutical compositions which contain them
Inventor: VIAUD MARIE-CLAUDE
IPC: C07D495/04
Filed: 1996-04-12
Abstract: Furo-, thieno- or pyrrolo-pyridine derivs. of formula (I), and their isomers and salts are new. X = O, S or NR7; R1-R4 = H, halo, OH, Ra or ORa; Ra = alkyl, haloalkyl, trialkylsilyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, or opt. substd. aryl or arylalkyl; either R5 = -A-B-Y; and R7 = H, alkyl, or opt. substd. aryl or arylalkyl; or R7 = -A-B-Y and R5 = as for R1-R4; A = 1-6C alkylene opt. substd. by one or more alkyl gps.; B = -NR6-C(=Z)- (B1), -NR6-C(=Z)-NH- (B2) or -C(=Z)-NR6- (B3); Y = H or Y1, but not H when B = B3; Y1 = alkyl, haloalkyl, alkenyl, alkynyl, cycloalkyl or cycloalkylalkyl; Z = O or S; R6 = H, alkyl, cycloalkyl, cycloalkylalkyl, aryl or arylalkyl; provided that: (a) (I) is not N-(2-(1H-pyrrolo Ä3,2-cÜ pyridin-3-yl) ethyl)- acetamide; and (b) R7 is not phenyl when the N atom of the pyridine ring is in position 7 of the heterocycle, R1 = alkyl in position 4 of the heterocycle, and R2-R4 = H; alkyl, alkoxy = 1-6C; alkenyl, alkynyl = 2-6C; cycloalkyl = 3-8C; aryl = phenyl, naphthyl or pyridyl; substd. aryl or arylalkyl has one or more substits. selected from halogen, alkyl, alkoxy, OH and haloalkyl.
Patent AU-5073300-A (AU)
Title: Method and device for treating milk, especially breast milk
Inventor: JAHN GERHARD
IPC: A23C1/00
Filed: 2000-05-29
Abstract: A device for treating milk contained in a container is disclosed. The device comprises at least one heat source that comprises an air bath, a device for setting the container in motion and exposing the container to the heat source for a defined period of time, and a cooling source for cooling the milk.
Patent AU-5136899-A (AU)
Title: Injectable propofol formulations
Inventor: KOMER GENE
IPC: A61K47/22
Filed: 1999-07-30
Abstract: The invention provides injectable formulations of propofol using N-methylpyrrolidone or 2-pyrrolidone as a solvent. Formulations of the invention are useful in all medical and veterinary indications when propofol is presently used. In addition, combinations of propofol and an appropriate toxin are useful for fast-acting, humane, veterinary euthanasia injectable compositions. N-methylpyrrolidone-propylene glycol formulations are inherently bacteriostatic, thereby eliminating one of the problems associated with currently available formulations.
Patent AU-5224999-A (AU)
Title: Methods for treating conditions modulated by lactosylceramide
Inventor: CHATTERJEE SUBROTO
IPC: A61P17/02
Filed: 1999-07-22
Abstract: The present invention includes methods for treatment and prophylaxis of conditions associated with lactosylceramide. The methods generally provide for administration to a mammal, particularly a human, of a therapeutically effective amount of a compound that increases enzymatic activity of UDPGal:GlcCerbeta1->4 galactosylceramide (GalT-2). In vitro and in vivo assays for detecting compounds with therapeutic capacity to modulate GalT-2 are also provided.
Patent AU-5233886-A (AU)
Title: Needle matrix printer
Inventor: JACQUES VERMOT-GAUD
IPC: B41J2/25
Filed: 1985-12-16
Abstract: PCT No. PCT/CH85/00176 Sec. 371 Date Aug. 19, 1986 Sec. 102(e) Date Aug. 19, 1986 PCT Filed Dec. 16, 1985 PCT Pub. No. WO86/03718 PCT Pub. Date Jul. 3, 1986.The printer comprises a series of needles (1) each associated to an electric lead (8) which extends in the gap of a permanent magnet (11). The extremities of each lead are fixed to respective supports (9,10) and are selectively connected to a current source to make a current (I) circulate in said leads so that, in the presence of a magnetic field in the air gap, a force (F) acts upon the lead (8) which communicates to the needle (I) an elongation (e) in the direction of the surface to be printed.
Patent AU-5252893-A (AU)
Title: Inhibitors of HIV protease useful for the treatment of AIDS
Inventor: JUNGHEIM LOUIS NICKOLAUS
IPC: C07D277/44
Filed: 1993-12-20
Abstract: The present invention provides novel HIV protease inhibitors of formula I, pharmaceutical formulations containing those compounds and methods of treating and/or preventing HIV infection and/or AIDS. <CHEM>  wherein:  R is a group having the formula: <CHEM>  R<2> is an amino acid side chain or -(CH2)y-X-R2a; y is 0, 1 or 2; and X, R<0>, R<3> and Y<1> are as defined in the application.
Patent AU-5301386-A (AU)
Title: Domestic bread making appliance
Inventor: GUNNAR HEDENBERG
IPC: A21D8/00
Filed: 1985-12-23
Abstract: An apparatus for automatically making food products in piece form from dough-like substances comprising a housing containing holding means (11) adapted to be affixed to either end of a flexible sealable bag (12) containing the ingredients for the dough-like substance, and a dough preparation station (13) having an upper and a lower slit forming slit openings (86); kneading means for mechanically working the ingredients in said bag, said kneading means including the holding means (11) and slit openings (86), and means for creating relative oscillating movement between the bag and the slit openings so that the ingredients are kneaded into a dough-like substance; and a heat treating station (14) in said housing whereby the kneaded dough-like substance is treated, said slit openings (86) each being defined by two guiding means such as sliding surfaces (87) or rollers (88). At least one of the guiding means (87, 88) of at least the upper slit is moveable relative to the other guiding means in that pair so as to allow gas to escape from the bag at the desired time.
Patent AU-5525099-A (AU)
Title: Treatment of mucus hypersecretion
Inventor: QUINN CONRAD PADRAIG
IPC: A61K47/48
Filed: 1999-08-25
Abstract: A method of treating mucus hypersecretion, the causative factor in chronic obstructive pulmonary disease (COPD), asthma and other clinical conditions involving COPD, comprises administering a compound that inhibits exocytosis in mucus secreting cells or neurones that control or direct mucus secretion. Also described is a compound, for use in the treatment of hypersecretion of mucus, which inhibits mucus secretion by inhibiting mucus secreting cells, and/or inhibiting neurotransmitter release from neuronal cells controlling or directing mucus secretion.</PTEXT>
Patent AU-5642499-A (AU)
Title: Locating underground power cable faults
Inventor: MILLER DAWN ELIZABETH
IPC: G01R31/12
Filed: 1999-09-07
Abstract: A method or means for locating cable faults comprises sampling gases near to a suspected cable fault 2 and testing the said sample using at least one gas sensor. The gas sensor output signal is monitored and is used to provide an indication of the location of a cable fault by identifying the presence of gases characteristic of underground cable faults. The signals from the gas sensor unit 5 may be monitored by a computer 10. A plurality of metal oxide semiconductor gas sensors with different sensitivities to different gases may be used in the gas sensor unit 5. The sensors may include a heater element for temperature control. Samples of gases may be drawn into the sensor unit 5 through a hollow probe 4 located in one or more holes in the ground 1 in the vicinity of the cable 3. A sample of air may be used to calibrate the sensors and the sensing arrangement may compensate for the air temperature and humidity.
Patent AU-5999294-A (AU)
Title: Mail sequencing process for mail sorting systems
Inventor: GILLMANN HANNO
IPC: B07C3/06
Filed: 1994-01-25
Abstract: In the method of the invention for sequencing parcels in mail-sorting facilities having rows of stacking compartments, a sorting plan is used for sorting the parcels in which an overfilling of the individual stacking compartments is avoided so that, during one sorting procedure, the stacking compartments are not emptied, and that, after a sorting procedure has ended, an in-sequence transfer of the parcels is effected from the stacking compartments into a conveying device disposed opposite the stacking compartments or into containers.
Patent AU-6066798-A (AU)
Title: Network controller for cable television delivery systems
Inventor: HENDRICKS JOHN S
IPC: G06F17/00
Filed: 1998-04-06
Abstract: A novel advanced set top terminal capable of digital decompression, menu generation, interactivity and other advanced functional capabilities for use in a television program delivery system (200) is described. The invention relates to methods and apparatus for upgrading existing set top terminals (220) to provide menu generation capability and advanced functional capabilities. The invention is particularly useful in television program delivery systems (200) with hundreds of channels of programming, providing (i) menu driven program selection through the addition of an upgrade module (300) or menu generation card and (ii) advanced functional capabilities using a set of hardware upgrades (e.g., 130) and/or an expansion card. Specifically, the invention is an upgradeable system that supports advanced set top functionality through the use of internal software, hardware upgrades, an upgrade module and/or expansion cards. The upgraded hardware generally includes a microprocessor, various input/output ports (e.g., 308), processing circuitry (e.g., 108) and memory (e.g., 116). The invention results in an upgraded set top terminal that supports: menu generation; picture-on-picture displays; program catalogue services; interactive services; telephone caller identification; digital audio reception; VCR control; HDTV reception; and backyard satellite system interoperability, among other features and capabilities.
Patent AU-6090296-A (AU)
Title: Process for preparation of biphenyl derivatives
Inventor: GIGUERE PIERRE
IPC: C07B61/00
Filed: 1996-06-06
Abstract: This application discloses a process for producing 8-[2'-(2(1)-tert-butyl-2H-tetrazol-5-yl) -biphenyl-4-yl-methyl]-2,4-dimethyl-5,8-dihydro-6H-pyrido[2,3-d]pyrimidin-7-one (or such a compound wherein a benzyl or p-methoxybenzyl group is present in place of the tert-butyl group) or a salt thereof, said process characterized in (B) transmetallizing bromo[2-[2-(tert-butyl)-2H-tetrazol-5-yl]phenyl]magnesium Grignard reagent with zinc chloride or bromide; and (C) reacting the transmetallized product with 8-[(4-bromophenyl)-methyl]5,8-dihydro-2,4-dimethyl-pyrido[2,3-d]pyrimidin-7(6H-one in the presence of a palladium catalyst to yield the product; wherein throughout the process a benzyl or p-methoxybenzyl group may be present in place of the tert-butyl group.
Patent AU-6231999-A (AU)
Title: Method for detecting atp
Inventor: LUNE HARRY VAN
IPC: G01N33/50
Filed: 1999-09-30
Abstract: The invention provides a method for detecting ATP in a sample, wherein the sample is contacted with a reaction mixture to effect a light signal, the reaction mixture comprising luciferin, luciferase and one or more water-soluble salts, the total salt concentration being at least 0.05 mole/liter, and wherein the light signal is measured. A kit is described for detecting ATP in a sample comprising luciferin, luciferase and a buffer solution comprising salts. A composition for detecting ATP in a sample comprising a total salt concentration of at least 0.05 mole/liter for prolonging a light signal occurring in a luciferin-luciferase reaction is also provided.
Patent AU-6258194-A (AU)
Title: Polymer polyols
Inventor: VANDICHEL JEAN-CLAUDE NOEL ELI
IPC: C08G65/32
Filed: 1994-03-03
Abstract: A process for preparing a polymer-modified polyol, which process comprises polymerising an olamine with a polysisocyanate in the presence of a polyol and of a stabiliser which is itself an olamine polymer-modified polyol.
Patent AU-6269096-A (AU)
Title: Fluorescence resonance energy transfer screening assay for the identification of HIV-1 envelope glycoprotein-medicated cell
Inventor: ALLAWAY GRAHAM P
IPC: C07K16/28
Filed: 1996-06-07
Abstract: This invention provides: agents determined to be capable of specifically inhibiting the fusion of a macrophage-tropic primary isolate of HIV-1 to a CD4+ cell, but not a T cell-tropic isolate of HIV-1 to a CD4+ cell; and agents determined to be capable of specifically inhibiting the fusion of a T cell-tropic isolate of HIV-1 to a CD4+ cell, but not a macrophage-tropic primary isolate of HIV-1 to a CD4+ cell. This invention also provides: agents capable of specifically inhibiting the fusion of a macrophage tropic primary isolate of HIV-1 with a CD+ cell susceptible to infection by a macrophage-tropic primary isolate of HIV-1; and agents capable of specifically inhibiting the fusion of a T cell-tropic isolate of HIV-1 with a CD4+ cell susceptible to infection by a T cell-tropic isolate of HIV-1. The agents include but are not limited to antibodies. This invention further provides: methods of inhibiting fusion of a macrophage-tropic primary isolate of HIV-1 with a CD+ cell susceptible to infection by a macrophage-tropic primary isolate of HIV-1 which comprises contacting the CD4+ cell with an amount of an agent capable of specifically inhibiting such fusion so as to thereby inhibit such fusion; and methods of inhibiting fusion of a T cell-tropic isolate of HIV-1 with a CD4+ cell susceptible to infection by a T cell-tropic isolate of HIV-1 which comprises contacting the CD4+ cell with an amount of an agent capable of specifically inhibiting such fusion so as to thereby inhibit such fusion.
Patent AU-6353380-A (AU)
Title: N-aryl-n:-imidazol-2-ylureas
Inventor: RASMUSSEN C R
IPC: C07D233/88
Filed: 1980-10-21
Abstract: N-aryl-N min -imidazol-2-ylureas useful for their antihypertensive, antidiarrheal, anti-irritable bowel syndrome, and anti-secretory activities.
Patent AU-6357596-A (AU)
Title: Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders
Inventor: GOZZINI LUIGIA
IPC: A61K35/74
Filed: 1996-06-19
Abstract: PCT No. PCT/EP96/02650 Sec. 371 Date Dec. 12, 1997 Sec. 102(e) Date Dec. 12, 1997 PCT Filed Jun. 19, 1996 PCT Pub. No. WO97/00688 PCT Pub. Date Jan. 9, 1997The present invention refers to pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders.
Patent AU-6363486-A (AU)
Title: Promoter arrangement for streptomycetes vectors
Inventor: KOLLER KLAUS-PETER
IPC: C12N1/21
Filed: 1986-10-09
Abstract: Arrangement, in the correct reading frame, of two promoters which are active in Streptomycetes results in enhanced expression of the relevant structural gene in Streptomycetes.
Patent AU-6384594-A (AU)
Title: Aluminium alloy brazing sheet
Inventor: GRAY ALAN
IPC: C22C21/00
Filed: 1994-04-05
Abstract: PCT No. PCT/GB94/00724 Sec. 371 Date Nov. 28, 1995 Sec. 102(e) Date Nov. 28, 1995 PCT Filed Apr. 5, 1994 PCT Pub. No. WO94/22633 PCT Pub. Date Oct. 13, 1994Aluminum brazing alloy composition is (in wt. %): Mn 0.7-1.5, Cu 0.5-1.0, Fe not more than 0.4, Si not more than 0.15, Mg up to 0.8, V and/or Cr up to 0.3, Ti up to 0.1, others up to 0.05 each, 0.15 total, balance A1 of at least commercial purity. Improved properties include: post-brazed strength and sag resistance; corrosion resistance; ability to withstand interannealing and some homogenization.
Patent AU-6427200-A (AU)
Title: An electrical operator device for windows
Inventor: KIRK HENNING SAND
IPC: E05F15/60
Filed: 2000-08-10
Abstract: An electric operator device (1) for opening and closing a window (2) with pivotal sash (5) and comprising an operator housing (4) designed to be fastened to the frame (3) of the window, preferably to the top member thereof, said operator housing having a built-in drive motor in transmission connection with an operating member (6), which in the closed position of the window is accommodated in the operator housing (4), and a mounting bracket (9) for connecting the operating member (6) with an operating means (7), connected with the sash of the window, preferably the top member thereof. The window (2) can, in the closed position and affected by said operating means (7), be locked by engagement between locking means (11) in connection with the sash (3), preferably the top member thereof, and a strike plate (8) fastened to the frame (5), preferably to the top member thereof. The electric operator device is characterized in that the operator housing (4) comprises a strike plate (8) which is fixedly positioned relative to the frame (3) by means of co-operating positioning means (13, 16, 17) arranged on the frame (3) and the strike plate (8).
Patent AU-6464194-A (AU)
Title: Turntable
Inventor: JANISCH KLAUS
IPC: A61G5/00
Filed: 1994-06-09
Abstract: A cover plate (12) with cushioned mat (18) is rotatably mounted on a bottom plate (16). The cushioned mat (18) is fixed on the cover plate (12) by an integral, rigid retention ring (20), an inner bead (34) of the retention ring (20) engaging clampingly under an outer bead (26) of the cover plate (12). An annular groove (22) near the outer edge of the cover plate (12) causes the remaining annular wall (24) with the marginal bead (26) to be connected to the rotating plate (12) only via a thin web, this web representing a bending zone (28), so that when the retention ring (20) is lifted off the annular wall (24) acts as a resilient tongue and can be moved elastically inwards. <IMAGE>
Patent AU-6519090-A (AU)
Title: Conjugate vaccine for group B streptococcus
Inventor: MICHEL JAMES L
IPC: A61K39/385
Filed: 1990-09-14
Abstract: A vaccine capable of protecting a recipient from infection caused by group B Streptococcus. The vaccine is formed by conjugating (a) a polysaccharide conjugated to (b) a protein; wherein both the polysaccharide and the protein are characteristic molecules of the group B Streptococcus.
Patent AU-6616301-A (AU)
Title: Modification of hepatitis b core antigen
Inventor: PAGE MARK
IPC: C07K19/00
Filed: 2001-06-22
Abstract: A protein is provided comprising hepatitis B core antigen (HBcAg) wherein one or more of the four arginine repeats has been deleted, said protein comprising the C-terminal cysteine of HBcAg. The deleted region may be replaced by an epitope from a protein other than HBcAg, in which case the HBcAg acts as a carrier to present the epitope to the immune system. The chimeric protein is useful in prophylactic and therapeutic vaccination of a host, for example against hepatitis B virus.
Patent AU-6756287-A (AU)
Title: Nicorandil-containing preparation for injection
Inventor: ISHIHARA KOIJI
IPC: A61K31/455
Filed: 1987-01-14
Abstract: A non-liquid type preparation for injection that has improved stability contains N-(2-hydroxyethyl)-nicotinamide nitrate ester (generally known as nicorandil) and an inorganic or organic acid and/or an alkaline metal salt thereof. These ingredients, together with an excipient that is pharmaceutically acceptable, may be dissolved in a solvent, sterilized by filtration and freeze-dried to obtain a freeze-dried preparation, or may be dissolved in a solvent under an aseptic condition and recrystallized to obtain an injectalbe powder. Nicorandil preparations according to the present invention are very stable and useful in clinical applications.
Patent AU-6981898-A (AU)
Title: Combination of a progestational agent and a nitric oxide synthase substrate and/or donor for the treatment of preeclampsia and preterm labor
IPC: A61K31/198
Filed: 1998-05-29
Abstract: Preeclampsia and preterm labor in a pregnant female mammal are treated by administering thereto a combination of a progestin and a nitric oxide synthase substrate, a nitric oxide donor or both, optionally in further combination with one or more of a cyclooxygenase inhibitor, a PGI2-mimetic, a thromboxane (TXA2) inhibitor, a compound possessing TXA2-agonistic and TXA2-inhibiting properties, a compound possessing TXA2-antagonistic and PGI2-memetic activities, and a TXA2 antagonist.
Patent AU-7020000-A (AU)
Title: Herbal compositions for itchy or infected skin
Inventor: SHAH ELADEVI
IPC: A61K/
Filed: 2000-09-04
Abstract: Compositions comprising an extract from the seeds of the plant <I>Centratherum anthelminticum</I> are suitable for use in the treatment of skin disorders, such as acne and impetigo, and fungal infections of the skin and nails. The composition is especially useful for the treatment of acne which results from bacterial infection by <I>Staphylococcus sp</I>., <I>Pitirosporunm sp</I>. and/or <I>Propionaebacterium sp</I>. The composition may also include an extract from the leaves, bark or roots of <I>Melia azardirachta</I> and/or an extract from the seeds of the plant <I>Casia tora</I>. A number of other plant extracts may be present in the composition also. The compositions are preferably formulated in powder form which may then be made up as a potable decoction, <I>i.e</I>., a drink; a mouthwash or as drops for nasal application. Alternatively, the composition may be dispersed in a suitable carrier for topical application, such as Ghee. Compositions comprising <I>Casia tora</I> and one or more of a variety of plant extracts including <I>Melia azardirachta</I> or compositions comprising <I>Melia azardirachta</I> and one or more of a variety of plant extracts including <I>Centratherum anthelminticum</I> are also suitable for use in the treatment of skin disorders and fungal infections of the skin and nails.
Patent AU-7111581-A (AU)
Title: Imidazole derivatives
Inventor: DERUNGS R
IPC: C07D233/58
Filed: 1981-05-28
Abstract: Imidazole derivatives of the formula    <IMAGE>  I  wherein X is hydrogen or C1-4-n-alkyl and Y is thienyl, optionally substituted by methyl or fluorine, or a group of the formula    <IMAGE> Y1  wherein R1, R2 and R3 independently are hydrogen, methyl, fluorine, hydroxy or methoxy, or two of R1, R2 and R3 on adjacent carbon atoms taken together are methylenedioxy or ethylenedioxy, or one of R1, R2 and R3 is mono- or di-(C1-4-n-alkyl)-amino and the other two are hydrogen, and physiologically compatible or pharmaceutically acceptable acid addition salts thereof, are described. These compounds of formula I inhibit the aggregation of the blood platelets.